Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 72,000 shares at $2.83 ($200K) on 2023-09-12, disclosed to the SEC on 2023-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.89 | 25,000 | $72K | 36.1% |
| 2 | $2.83 | 30,000 | $85K | 42.4% |
| 3 | $2.58 | 10,000 | $26K | 12.9% |
| 4 | $2.49 | 7,000 | $17K | 8.7% |
| Total | $2.78 avg | 72,000 | $200K | 100% |
| Filing → |
| IMMX | BUY | 2024-07-31 | $20K | — | Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-12 | $25K | — | Filing → |